fanapanel inn code name also known mpqx quinoxalinedione derivative drug acts competitive antagonist ampa development schering ag treatment cerebral ischemia associated stroke trauma clinical trials halted safety reasons related possible glial cell toxicity due intolerable side effects excessive sedation reduction consciousness consisting stupor coma transient neurological drug also observed produce visual alteration impairment including blurred vision strongly impaired color perception reduced visual acuity dark vision side effects thought caused blockade ampa receptors drug article relating nervous system stub help wikipedia expanding httpsenwikipediaorgwikifanapanel